Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities
Stock Information for Hoth Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.